Nakamori, Masahiro https://orcid.org/0000-0002-0944-5538
Toko, Megumi
Yamada, Hidetada
Hayashi, Yuki
Ushio, Kai
Yoshikawa, Kohei
Haruta, Azusa
Hiraoka, Aya
Yoshikawa, Mineka
Nagasaki, Toshikazu
Mikami, Yukio https://orcid.org/0000-0001-6855-8439
Maruyama, Hirofumi https://orcid.org/0000-0001-7613-8717
Article History
Received: 13 November 2023
Accepted: 28 November 2023
First Online: 6 December 2023
Declarations
:
: This research was approved by the Certified Review Board of Hiroshima University (Hiroshima, Japan) (approval number: CRB6180006) and was conducted in accordance with the national government’s regulations following the Helsinki Declaration of 1964. The study was registered with jRCT (jRCTs062220013). Written informed consent was obtained from all participating patients.
: Hirofumi Maruyama received honoraria from Eisai, Shionogi, Otsuka Pharmaceutical, and Sumitomo Pharma.